Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Active substance : ganciclovir
  • Active substance : rituximab
  • Date : du 14/09/2014 au 14/09/2018
  • Topics : Blood and lymphatic diseases
  • Topics : Diseases and conditions
  • Topics : Diagnostic and therapeutic techniques
Filter
Topic
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Transfusions, transplantations (1)
    • Diagnostic techniques and procedures (1)
    • Plus ...
      • Biology (laboratory tests) (1)
  • Diseases and conditions (1)
  • Plus ...
    • Infectious diseases (1)
    • Plus ...
      • Virus diseases (1)
    • Blood and lymphatic diseases (1)
    • Plus ...
      • Lymphatic diseases (1)
      • Hematologic cancers (1)
    • Immune system diseases (1)
    • Plus ...
      • Immune system diseases - miscellaneous (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Health technology assessment (1)
Date
  • Last five years (1)
Language
  • Français (1)
Active substance
  • ganciclovir (1)
  • rituximab (1)

Drugs, devices and medical acts - 1 result

  • Laboratory examinations to test for Epstein-Barr virus as part of post-transplant lymphoproliferative disorder

    Health technology assessment - Posted on 20/11/2015
    Download document
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
5kgbLfFMJfvzF0fK